-
NTLA Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
Intellia Therapeutics (NTLA)
Company Profile
Quarter (USD) | Sep 24 | Mar 24 | Dec 23 | Sep 23 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 134.10 mm | 134.10 mm | 134.10 mm | 134.10 mm | 134.10 mm | |
Cash burn (monthly) | 17.16 mm | 4.14 mm | 48.26 mm | 44.15 mm | 26.26 mm | |
Cash used (since last report) | 47.82 mm | 11.53 mm | 134.45 mm | 123.01 mm | 73.16 mm | |
Cash remaining | 86.28 mm | 122.57 mm | -354.53 k | 11.09 mm | 60.94 mm | |
Runway (months of cash) | 5.0 | 29.6 | -0.0 | 0.3 | 2.3 |
13F holders | Current |
---|---|
Total holders | 293 |
Opened positions | 49 |
Closed positions | 40 |
Increased positions | 112 |
Reduced positions | 87 |
13F shares | Current |
---|---|
Total value | 1.92 tn |
Total shares | 95.97 mm |
Total puts | 852.90 k |
Total calls | 673.10 k |
Total put/call ratio | 1.3 |
Largest owners | Shares | Value |
---|---|---|
ARK Investment Management | 11.60 mm | $259.51 bn |
BLK BlackRock | 9.60 mm | $214.79 bn |
Vanguard | 9.10 mm | $203.66 bn |
Deep Track Capital | 4.80 mm | $107.42 bn |
STT State Street | 4.36 mm | $97.64 bn |
REGN Regeneron Pharmaceuticals | 3.70 mm | $437.84 mm |
CMTDF Sumitomo Mitsui Trust | 3.26 mm | $72.91 bn |
Nikko Asset Management Americas | 3.26 mm | $72.91 bn |
MS Morgan Stanley | 2.34 mm | $52.32 bn |
FHI Federated Hermes | 2.30 mm | $51.49 bn |
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
2 Oct 24 | Michael P Dube | Common Stock | Sell | Dispose S | No | No | 19.01 | 2,012 | 38.25 k | 47,012 |
22 Jul 24 | Edward J Dulac III | Common Stock | Grant | Acquire A | No | No | 0 | 66,324 | 0.00 | 66,324 |
22 Jul 24 | Edward J Dulac III | Stock Option Common Stock | Grant | Acquire A | No | No | 25.33 | 96,219 | 2.44 mm | 96,219 |
1 Jul 24 | Eliana Clark | Common Stock | Sell | Dispose S | No | No | 22.93 | 405 | 9.29 k | 71,470 |
1 Jul 24 | Michael P Dube | Common Stock | Grant | Acquire A | No | No | 0 | 17,801 | 0.00 | 49,024 |